Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Software Development
Sydney, New South Wales-based RoseRx operates in Software Development. Ownership is privately held; it publishes at roserx.health. The record carries two addresses across two office countries. The record counts 18 people. Tagged automation, agentic ai and conversational ai. One Australian registration (ABN) is a confirmed match. Its latest round on record is Series A, US$4.9M. It is listed alongside eight similar brands, mostly in Advertising Services.
ABN55666502049
| ROSERX PTY LTD | ABN 55666502049 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
RoseRx turns MLR-approved materials into compliant AI agents for patient and doctor conversations. Every conversation generates commercial intelligence that accelerates patient access to life changing treatments.
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU US
| Rounds | 3 |
|---|---|
| Axis | 2022 to 2026 |
| Series A · 8 Oct 2021 | US$ 4.9M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One New South Wales entity on the ABR. ROSERX PTY LTD (ABN 55 666 502 049), high confidence.
The record holds 18 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Two addresses on record across 2 countries. Primary: L17, International Tower 3, Barangaroo Ave, Sydney, New South Wales 2000.
Three rounds. Latest 8 October 2021: Series A, US$4,900,000, investor Breyer Capital.
Six tags on the brand's own list, among them automation, agentic ai and conversational ai.
11 profiles list RoseRx as a peer — 93rd percentile in Software Development. It lists ten peers of its own. Eratos and SuperEd Pty Ltd list it back.